ReviewCancers2024

Mechanistic Insights into the Successful Development of Combination Therapy of Enfortumab Vedotin and Pembrolizumab for the Treatment of Locally Advanced or Metastatic Urothelial Cancer.

Caroline Taylor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.